Proxy Votes Now

Home › Funds › BNY Mellon › BNY Mellon US Small Cap Core Equity ETF

BNY Mellon US Small Cap Core Equity ETF (BKSE) proxy voting record 2025-2026

Fund family: BNY Mellon · Filed by BNY Mellon ETF Trust (CIK 1493580) · SEC series S000067262

Ticker: BKSE (C000216364)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 5,332 with, 28 against, 0 abstentions (not counted as with management). Shareholder proposals: 7 FOR, 19 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with BNY Mellon as a whole

The same two figures as BNY Mellon’s manager page (141,760 ballot items across 60 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBNY MellonItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)90.6%5,20993.1%117,600
Backed environmental and social shareholder proposals at US companiesn/a61.8%1,473

Where this fund voted differently from most BNY Mellon funds

Each ballot item this fund voted is set against the votes of the other BNY Mellon funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most BNY Mellon funds on 67 items (4.4% of the 1,507 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost BNY Mellon fundsMgmtResult
JFrog Ltd.2026-05-20Election of Directors: Elisa SteeleAgainstFOR — 7 of 7 BNY Mellon fundsAgainstPassed (calculated), 70.7% support
JFrog Ltd.2026-05-20Election of Directors: Yossi SelaForAGAINST — 7 of 7 BNY Mellon fundsForPassed (calculated), 95.9% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciWithholdFOR — 5 of 5 BNY Mellon fundsAgainstElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyWithholdFOR — 5 of 5 BNY Mellon fundsAgainstElected, 86.8% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn ShookWithholdFOR — 5 of 5 BNY Mellon fundsAgainstElected, 82.2% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jacqueline KosecoffWithholdFOR — 5 of 5 BNY Mellon fundsAgainstElected, 76.1% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jody BilneyWithholdFOR — 5 of 5 BNY Mellon fundsAgainstElected, 76.1% support
Rhythm Pharmaceuticals, Inc.2026-06-24Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrWithholdFOR — 4 of 4 BNY Mellon fundsAgainstPassed (calculated), 85.9% support
Viking Therapeutics, Inc.2026-05-19TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.ForAGAINST — 4 of 4 BNY Mellon fundsForApproved, 70.2% support
Weatherford International plc2026-06-11Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they consAgainstFOR — 6 of 7 BNY Mellon fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary shaAgainstFOR — 6 of 7 BNY Mellon fundsAgainst—
Weatherford International plc2026-06-11To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement.AgainstFOR — 6 of 7 BNY Mellon fundsAgainstPassed (calculated), 63.9% support
Weatherford International plc2026-06-11To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatelAgainstFOR — 6 of 7 BNY Mellon fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To approve any motion to adjourn the AGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the AGM to approve the resolutions proposed at the AGM.AgainstFOR — 6 of 7 BNY Mellon fundsAgainst—
Weatherford International plc2026-06-11To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement.AgainstFOR — 6 of 7 BNY Mellon fundsAgainstPassed (calculated), 64.7% support
Weatherford International plc2026-06-11To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement.AgainstFOR — 6 of 7 BNY Mellon fundsAgainstPassed (calculated), 66.3% support
Synaptics Incorporated2025-10-28Proposal for the Election of Directors: Patricia KummrowAgainstFOR — 6 of 7 BNY Mellon fundsAgainstElected, 90.0% support
Synaptics Incorporated2025-10-28Proposal to approve the Company's amended and restated 2019 Equity and Incentive Compensation Plan.AgainstFOR — 6 of 7 BNY Mellon fundsAgainstApproved, 67.7% support
YETI Holdings, Inc.2026-05-07Election of four Class II directors: Arne ArensWithholdFOR — 6 of 7 BNY Mellon fundsAgainstElected, 75.5% support
YETI Holdings, Inc.2026-05-07Election of four Class II directors: Mary Lou KelleyWithholdFOR — 6 of 7 BNY Mellon fundsAgainstElected, 66.7% support
Transocean Ltd.2026-05-22Election of 11 Directors, Each for a Term Extending Until Completion of the Next Annual General Meeting: Frederico F. CuradoForAGAINST — 3 of 3 BNY Mellon fundsForElected, 87.2% support
Transocean Ltd.2026-05-22Ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 and Reelection of Ernst & Young Ltd, Zurich, as the Company's Auditor for a Further One Year TermForAGAINST — 3 of 3 BNY Mellon fundsFor—
Disc Medicine, Inc.2026-06-18To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.WithholdFOR — 3 of 3 BNY Mellon fundsAgainstPassed (calculated), 84.2% support
PennyMac Financial Services, Inc.2026-06-03To elect the ten (10) director nominees identified in the enclosed Proxy Statement to serve on our Board of Directors, each for a one-year term expiring at the 2027 Annual Meeting of Stockholders: Doug JonesAgainstFOR — 3 of 3 BNY Mellon fundsAgainstPassed (calculated), 99.5% support
GeneDx Holdings Corp.2026-06-18Election of Director: Katherine StuelandWithholdFOR — 3 of 3 BNY Mellon fundsAgainstPassed (calculated), 75.7% support
Show all 67
Items 26 to 67.
CompanyMeetingItemThis fundMost BNY Mellon fundsMgmtResult
The Timken Company2026-05-08Shareholder Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percAgainstFOR — 4 of 5 BNY Mellon fundsForNot approved, 41.4% support
The Timken Company2026-05-08Ratification of the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending December 31, 2026.ForAGAINST — 4 of 5 BNY Mellon fundsForPassed (calculated), 96.9% support
EnerSys2025-07-31Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year ending March 31, 2026.ForAGAINST — 4 of 5 BNY Mellon fundsForApproved, 96.0% support
Brunswick Corporation2026-05-06The Election to Brunswick's Board of Directors of the ten nominees named in the Proxy Statement: David C. EverittForAGAINST — 4 of 5 BNY Mellon fundsFor—
Visteon Corporation2026-06-11Elect the eight director nominees named in the proxy statement to hold office until the next annual stockholders' meeting: Robert J. ManzoForAGAINST — 4 of 5 BNY Mellon fundsForPassed (calculated), 94.3% support
Bank OZK2026-05-18Election of Directors: Nicholas BrownForAGAINST — 4 of 5 BNY Mellon fundsFor—
Rhythm Pharmaceuticals, Inc.2026-06-24Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.ForAGAINST — 5 of 7 BNY Mellon fundsForApproved, 81.5% support
Moelis & Company2026-06-25Election of Directors: Eric CantorAgainstFOR — 5 of 7 BNY Mellon fundsAgainstPassed (calculated), 97.8% support
Moelis & Company2026-06-25Election of f Directors: Louise MirrerAgainstFOR — 5 of 7 BNY Mellon fundsAgainstPassed (calculated), 84.0% support
Mirum Pharmaceuticals, Inc.2026-06-15To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.ForAGAINST — 6 of 9 BNY Mellon fundsForApproved, 96.0% support
Darling Ingredients Inc.2026-05-07Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 2, 2027.ForAGAINST — 4 of 6 BNY Mellon fundsForPassed (calculated), 92.2% support
Americold Realty Trust, Inc.2026-05-18Shareholder Advisory Vote on Shareholder Proposal Regarding Director Removal With or Without Cause.AgainstFOR — 3 of 4 BNY Mellon fundsForPassed (calculated), 61.8% support
Belden Inc.2026-05-21Ratification of the appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm for 2026.ForAGAINST — 3 of 4 BNY Mellon fundsForPassed (calculated), 96.7% support
COPT Defense Properties2026-05-14Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the current fiscal year.ForAGAINST — 3 of 4 BNY Mellon fundsFor—
RH2026-06-18Election of Directors: Ali RowghaniWithholdFOR — 3 of 4 BNY Mellon fundsAgainstPassed (calculated), 94.5% support
John Wiley & Sons, Inc.2025-09-25The election as directors of all nominees listed below, except as marked to the contrary: Brian O. HemphillWithholdFOR — 4 of 6 BNY Mellon fundsAgainstPlurality election, 45.6% support
Texas Capital Bancshares, Inc.2026-04-21To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt any of Proposals 2-5; andForAGAINST — 3 of 4 BNY Mellon fundsForNot approved, 31.1% support
Texas Capital Bancshares, Inc.2026-04-21To approve the redomestication of the Company from Delaware to Texas by way of conversion;ForAGAINST — 3 of 4 BNY Mellon fundsForNot approved, 45.2% support
Texas Capital Bancshares, Inc.2026-04-21To approve, on an advisory basis, increasing the threshold to submit stockholder proposals;ForAGAINST — 3 of 4 BNY Mellon fundsForNot approved, 12.9% support
Texas Capital Bancshares, Inc.2026-04-21To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026;ForAGAINST — 3 of 4 BNY Mellon fundsForApproved, 98.3% support
Lumentum Holdings Inc.2025-11-19To approve, on a non-binding, advisory basis, the compensation of our named executive officers.ForAGAINST — 5 of 9 BNY Mellon fundsForPassed (calculated), 88.9% support
Southwest Gas Holdings, Inc.2026-05-07To APPROVE, on a non-binding, advisory basis, the Company's executive compensation.ForAGAINST — 5 of 9 BNY Mellon fundsForPassed (calculated), 97.7% support
Blackbaud, Inc.2026-06-10ADVISORY VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.ForAGAINST — 5 of 9 BNY Mellon fundsForApproved, 98.3% support
GeneDx Holdings Corp.2026-06-18Approval, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 4 of 7 BNY Mellon fundsForPassed (calculated), 93.9% support
Arrow Electronics, Inc.2026-05-12To approve, by non-binding vote, named executive officer compensation.ForAGAINST — 3 of 5 BNY Mellon fundsFor—
Meritage Homes Corporation2026-05-21Shareholder Shareholder proposal to improve shareholder ability to call for a special shareholder meeting.AgainstFOR — 3 of 5 BNY Mellon fundsForNot approved, 25.6% support
United Community Banks, Inc.2026-05-13Election of Directors: Thomas A. RichlovskyForWITHHOLD — 3 of 5 BNY Mellon fundsForElected, 96.0% support
Magnite, Inc.2026-06-08Approval, on an advisory basis, of the compensation of the Company's named executive officers.ForAGAINST — 3 of 5 BNY Mellon fundsForApproved, 89.2% support
Hayward Holdings, Inc.2026-05-21Election of Directors: Arthur SoucyWithholdFOR — 3 of 5 BNY Mellon fundsAgainstElected, 65.3% support
Hayward Holdings, Inc.2026-05-21Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.ForAGAINST — 3 of 5 BNY Mellon fundsForPassed (calculated), 97.7% support
Simmons First National Corporation2026-05-13To ratify the Audit Committee's selection of the accounting firm Forvis Mazars, LLP as independent auditors of the Company and its subsidiaries for the year ending December 31, 2026.ForAGAINST — 3 of 5 BNY Mellon fundsForPassed (calculated), 95.8% support
BankUnited, Inc.2026-05-21To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan.ForAGAINST — 3 of 5 BNY Mellon fundsForPassed (calculated), 60.2% support
SkyWest, Inc.2026-05-05Shareholder A shareholder proposal regarding collective bargaining policy.AgainstFOR — 3 of 5 BNY Mellon fundsFor—
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesForWITHHOLD — 3 of 5 BNY Mellon fundsForElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliForWITHHOLD — 3 of 5 BNY Mellon fundsForElected, 83.6% support
LCI Industries2026-05-12To ratify the appointment of KPMG LLP as independent auditor for the Company for the year ending December 31, 2026.ForAGAINST — 3 of 5 BNY Mellon fundsForPassed (calculated), 96.7% support
Littelfuse, Inc.2026-04-22Election of Directors: Maria C. GreenAgainstFOR — 2 of 3 BNY Mellon fundsAgainstPassed (calculated), 93.9% support
The Hanover Insurance Group, Inc.2026-05-12The ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company's independent, registered public accounting firm for 2026.ForAGAINST — 2 of 3 BNY Mellon fundsForPassed (calculated), 97.7% support
CNO Financial Group, Inc.2026-05-12Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.ForAGAINST — 2 of 3 BNY Mellon fundsForApproved, 97.9% support
The Boston Beer Company, Inc.2026-05-27Election of Directors: Cynthia L. SwansonWithholdFOR — 2 of 3 BNY Mellon fundsAgainst—
The Boston Beer Company, Inc.2026-05-27Election of Directors: Joseph H. JordanWithholdFOR — 2 of 3 BNY Mellon fundsAgainst—
The Boston Beer Company, Inc.2026-05-27Election of Directors: Meghan V. JoyceWithholdFOR — 2 of 3 BNY Mellon fundsAgainst—

Download all 67 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.3% of this fund’s 5,360 such votes could be given a sector; the other 197 (3.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary1,193171.4%
Finance1,03200.0%
Industrials67550.7%
Technology64240.6%
Health Care55710.2%
Real Estate32610.3%
Energy27900.0%
Utilities19600.0%
Consumer Staples8300.0%
Miscellaneous8200.0%
Basic Materials5700.0%
Telecommunications4100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3,7862
Say-on-Pay6172
Audit-related5800
Compensation1760
Corporate Governance13117
Extraordinary Transactions530
Capital Structure500
Shareholder Rights and Defenses111
Environment or Climate22
Human Rights or Human Capital/workforce22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Sandisk CorporationNovember 18, 2025$3M100
Lumentum Holdings Inc.November 19, 2025$1M110
Nextracker Inc.August 18, 2025$735,28950
Glaukos CorporationMay 28, 2026$490,99440
Modine Manufacturing CompanyAugust 21, 2025$406,41560
e.l.f. Beauty, Inc.August 21, 2025$400,89350
Columbia Banking System, Inc.July 21, 2025$393,22620
Cirrus Logic, Inc.July 29, 2025$386,36590

Notable votes against management

MeetingCompanyProposalFundMgmt
May 12, 2026Arrow Electronics, Inc.Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold. Shareholder proposalAgainstFor
June 9, 2026Etsy, Inc.Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposalForAgainst
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 8, 2026The Timken CompanyConsideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposalAgainstFor
May 14, 2026Wyndham Hotels & Resorts, Inc.To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposalForAgainst
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
April 15, 2026Sonoco Products CompanyAdvisory (non-binding) shareholder proposal - avoid brand damage from political spending. Shareholder proposalAgainstFor
May 18, 2026Americold Realty Trust, Inc.Advisory Vote on Shareholder Proposal Regarding Director Removal With or Without Cause. Shareholder proposalAgainstFor
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
May 21, 2026Harley-Davidson, Inc.To vote on a shareholder proposal regarding a climate transition plan. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

5,411 ballot items at 621 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, BNY Mellon US Small Cap Core Equity ETF (BKSE) voted at 621 shareholder meetings of 594 companies, on 5,411 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 28 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 27 shareholder proposals. It voted FOR the board's own proposals less often than BNY Mellon's funds as a whole (90.6% against 93.1%). It voted differently from most BNY Mellon funds on 67 items. 4 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BNY Mellon’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.